Sanofi Ventures invests in top tier biotherapeutic and digital health entrepreneurs who focus on helping patients and transforming the healthcare system.
Investment Type: Venture Capital
Portfolio 1
| Date | Name | Website | Total Raised | Location |
| 27.04.2023 | Therini Bi... | therinibio.com | $53M | United Sta... |
Mentions in press and media 4
| Date | Title | Description |
| 10.02.2025 | AdvanCell Successfully Completes an Oversubscribed US$112M Series C Financing | Sydney, Australia – 3 February 2025 – AdvanCell, a clinical-stage radiopharmaceutical company developing innovative cancer therapeutics, today announced the successful completion of an oversubscribed US$112 million Series C financing. This ... |
| 11.01.2023 | Sanofi Ventures Announces Multi-Year Capital Commitment from Sanofi; Evergreen Fund Increases to $750M | Sanofi Ventures has announced an additional multi-year commitment from Sanofi (EURONEXT: SAN and NASDAQ: SNY), with an increase in capital to more than $750m to the evergreen venture fund. In addition to serving as a financial partner to to... |
| 14.12.2017 | NEA-backed Curisium Raises $3.5M Seed | Curisium, a healthcare technology and services company that enables innovative contracting at scale via its blockchain-based platform, announced today it has raised $3.5M in seed financing from Flare Capital Partners, New Enterprise Associa... |
| 14.12.2017 | Flare-backed Curisium Raises $3.5M Seed | Curisium, a healthcare technology and services company that enables innovative contracting at scale via its blockchain-based platform, announced today it has raised $3.5M in seed financing from Flare Capital Partners, New Enterprise Associa... |